Management of heel pressure ulcers among inpatients with diabetes by Cook, Leanne & Murphy, Nicola
University of Huddersfield Repository
Cook, Leanne and Murphy, Nicola
Management of heel pressure ulcers among inpatients with diabetes
Original Citation
Cook, Leanne and Murphy, Nicola (2013) Management of heel pressure ulcers among inpatients 
with diabetes. Wounds UK, 9 (1). S20-S23. ISSN 1746-6814 
This version is available at http://eprints.hud.ac.uk/19791/
The University Repository is a digital collection of the research output of the
University, available on Open Access. Copyright and Moral Rights for the items
on this site are retained by the individual author and/or other copyright owners.
Users may access full items free of charge; copies of full text items generally
can be reproduced, displayed or performed and given to third parties in any
format or medium for personal research or study, educational or not-for-profit
purposes without prior permission or charge, provided:
• The authors, title and full bibliographic details is credited in any copy;
• A hyperlink and/or URL is included for the original metadata page; and
• The content is not changed in any way.
For more information, including our policy and submission procedure, please
contact the Repository Team at: E.mailbox@hud.ac.uk.
http://eprints.hud.ac.uk/
 Wounds UK | Vol 9 | No 1 | Supplement 1 | 2013
Review
Management of heel pressure 
ulcers among inpatients  
with diabetes 
P
revalence of diabetes among adults is rising. In 
2011, 5.5% of the adult population in England 
and Wales were diagnosed with diabetes 
(NHS Diabetes, 2011) and 4.7% were diagnosed in 
Scotland, with a further 0.9% estimated as being 
undiagnosed (NHS Scotland, 2011). It is reported that 
in 2013 7.8% of the adult population in England will 
have diabetes (diagnosed and undiagnosed), and this 
is predicted to reach 8.5% in 2020 and 9.5% by 2030 
(Association of Public Health Observatories, 2012). 
The care of people with diabetes presents a 
significant financial burden to the NHS. The current 
total annual cost of direct patient care (treatment, 
intervention, and complications) is estimated to 
be £1 billion for people with type 1 diabetes and 
£8.8 billion for those with type 2 diabetes (Hex 
et al, 2012). The majority of these costs are spent 
on primary care services, but diabetic care also has 
a significant impact on secondary care budgets. The 
NHS in England spends more than £2 billion a year 
on inpatient care for people with diabetes, which 
equates to approximately 11% of the total NHS 
inpatient care expenditure (NHS Diabetes, 2011). 
People with diabetes are more likely to be 
admitted to hospital and experience a longer 
hospital stay when compared to others of a similar 
age admitted for similar conditions (NHS Diabetes, 
2011). With so many people with diabetes requiring 
acute inpatient care, we need to ensure the care 
they receive is appropriate. However, the National 
Diabetes Inpatient Audit (2010) found that there was 
cause for concern regarding the care of inpatients 
with diabetes in most hospitals. The Health and 
Social Care Information Centre (2012) repeated the 
audit in 2011, which showed some improvement, 
but there were still areas of concern. Nearly half of 
all diabetes-specific admissions were for foot disease 
and, of these, less than two-thirds were referred to a 
multidisciplinary foot care team (MDFCT).
NICE (2011) recommends that a MDFCT 
should manage the care pathway of people with 
diabetic foot problems who require inpatient care. 
The guideline states that the MDFCT should 
include a diabetologist, a surgeon with the relevant 
expertise in managing diabetic foot problems, a 
diabetes nurse specialist, a podiatrist, and a tissue 
viability nurse (TVN). 
Within England, specialist podiatrists are part of 
the MDFCT in 78% of cases, but TVNs are only 
present in 23% of teams; a further 71% of hospital 
sites reported that a TVN was not a member of the 
MDFCT, but was accessible when needed. Some 
7.1% of hospital sites reported they had no access 
to a specialist podiatrist and 5.5% of sites did not 
have access to a TVN service (Health and Social 
Care Information Centre, 2012). Within Wales, the 
figures were slightly improved; 72% of sites had a 
specialist podiatrist within their MDFCT, but 100% 
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Approximately 6000 people with diabetes undergo leg, foot, or toe amputations each 
year in England, many of which are avoidable. The risk of lower extremity amputation 
for people with diabetes is ≥20 times that of people without diabetes. Major amputation 
rates in people with diabetes vary ten-fold across primary care trusts (Diabetes UK, 
2012). The preceding event to limb amputation is often ulceration. This article discusses 
the management of heel pressure ulcers in patients with diabetes and questions whether 
there is a need for clearer guidance in regard to who is responsible for the patient’s care 
during a hospital stay. Additionally, the authors discuss whether care pathways need 
to be revised to ensure that patients are optimally managed, which could ultimately 
reduce the number of avoidable foot problems developing during acute hospital stays.
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of the sites reported having access to services when 
required. TVN presence in Wales was also slightly 
higher, at 39%. However, 5.6% of sites reported they 
had no access to tissue viability services (Health 
and Social Care Information Centre, 2012).
SIGN (2010) also recommends that people with 
active diabetic foot disease should be referred to 
a MDFCT. The membership is similar to that of 
NICE (2011), but SIGN does not state the need for 
a TVN on the team.
Inpatient care for people with diabetes was 
identified as a key area for improvement in the NHS 
Operating Framework for 2011/2012 (Department 
of Health, 2010). The framework set the priority 
that “NHS providers should consider the overall 
management of inpatients with diabetes in order to 
reduce their length of stay, improve their experience 
of care, ensure that patients do not develop diabetic 
foot complications while in hospital, and that their 
blood glucose is managed safely”. 
It is reported that up to 100 people a week 
in the UK have a limb amputated as a result of 
diabetes. People at highest risk are those who have 
a previous history of ulcers, neuropathy, or nerve 
damage and circulatory problems (Diabetes UK, 
2009). It is therefore concerning that in 2011 only 
26.8% of inpatients had documented evidence of 
a foot examination being performed at any time 
during their hospital stay (Health and Social Care 
Information Centre, 2012). 
In 2009, the NHS Institute for Innovation and 
Improvement highlighted eight “High Impact Actions 
for Nursing and Midwifery”, one of which was called 
“Your Skin Matters”. This action has the goal of “no 
avoidable pressure ulcers in NHS care” (NHS Institute 
for Innovation and Improvement, 2009). 
An intrinsic part of pressure ulcer prevention is 
the comprehensive assessment of the skin for every 
inpatient, so why is there such a low proportion 
of documented foot inspections? Is it because 
diabetic foot assessment and pressure ulceration 
assessments are seen as two separate entities? 
During a hospital stay pressure ulcers most 
commonly occur on the heels and overall heel 
ulceration is reported to be the second most 
common type of pressure ulcer (Fowler et al, 
2008). Risk factors for developing heel pressure 
ulcers include peripheral arterial disease, diabetic 
neuropathy, immobility of lower limbs due to 
surgery, paresis, structural deformity, and dementia 
(Younes et al, 2004; Gefen, 2010).
Diabetes is a major risk factor for heel pressure 
ulcers because it is frequently associated with 
peripheral arterial disease. Adding to the 
complications, arteriosclerosis tends to affect 
the distal vessels, which are less amenable to 
revascularisation. The European Pressure Ulcer 
Advisory Panel (EPUAP) and National Pressure 
Ulcer Advisory Panel (NPUAP; 2009a) recommend 
that every patient in any healthcare setting should 
be assessed regarding the risk of pressure ulceration 
and that strategies should be implemented to aid in 
preventing pressure ulcer formation. 
Risk calculation is often performed through the 
use of a tool such as the Waterlow Score or Braden 
Scale. These tools highlight that diabetes increases 
pressure ulcer risk, but neither tool requires the 
assessment of peripheral pulses or neuropathy. It 
is widely accepted that careful foot examination 
testing for neuropathy and arterial insufficiency 
can identify people who are at risk of developing 
heel ulcers. Within a community setting, people 
with diabetes, as a minimum, undergo annual foot 
assessments, which include palpation of foot pulses, 
foot sensation testing, inspection for any deformity, 
and of footwear. Following this assessment, patients 
are classified as low risk, increased risk, high risk, or 
ulcerated foot (NICE, 2004).
If a patient is admitted into secondary care, are the 
results of the foot risk assessment readily available to 
the hospital team? Should all patients with diabetes 
undergo foot assessment on admission to determine 
risk of developing ulceration? 
Diabetes UK (2009) and NICE (2011) both 
enforce best practice standards for patients 
with active foot problems, but are there further 
improvements that can be made by ensuring 
patients with diabetes but without ulceration are 
risk assessed and appropriately managed?
In terms of underlying pathology, a heel pressure 
ulcer on a patient with diabetes and a diabetic foot 
ulcer are often identical, as the reduction of the blood 
and or nerve supply reduces the tolerance of pressure. 
In terms of management, national variations exist and 
in some hospitals the patients are managed solely by 
the tissue viability services without the involvement 
of the MDFCT. In other locations, however, patients 
are referred directly to the MDFCT. 
“Heel ulceration 
is reported to be 
the second most 
common type of 
pressure ulcer.”
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Guidance for pressure ulceration (European 
Pressure Ulcer Advisory Panel, National Pressure 
Ulcer Advisory Panel, 2009b) does recognise the 
need for a focused physical examination, which 
includes factors that may affect healing (e.g. 
impaired perfusion, impaired sensation, systemic 
infection) and vascular assessment in the case 
of extremity ulcers (e.g. physical examination, 
history of claudication, and ankle brachial pressure 
index or toe pressure). EPUAP and NPUAP fail 
to mention the need for sensation testing in the 
patient with diabetes as well as to highlight the 
potential benefits of referring patients with heel 
pressure ulcers to the MDFCT. 
As previously discussed, in 23% of hospitals 
the TVN is part of the MDFCT, but what is the 
process for the other 77% of organisations? Who 
is ultimately responsible and accountable for the 
patient’s care? Do the current pathways comply 
with NICE (2011), which recommends a MDFCT 
should manage the care pathway of people with 
diabetic foot problems who require inpatient care?
Of all the ulcers seen in people with diabetes, 
heel ulcers are the most serious and often lead 
to below-the-knee amputation (Younes et al, 
2004). The management of heel ulcers requires 
a thorough knowledge of the major risk factors 
for ulceration in the heel area and a standardised 
programme of local ulcer care, metabolic control, 
early control of infection, and improvement of 
blood supply to the foot (Younes et al, 2004). 
If patients are appropriately risk assessed, then 
suitable interventions can be initiated to help 
prevent ulcer formation. These include maintaining 
good skin condition, repositioning the patient at 
regular intervals, providing appropriate equipment 
(mattresses, foam or air elevation devices 
specifically for the heel), and patient education 
regarding foot hygiene, skin care, and appropriate 
footwear. However, Wijenaikke and Leese (2001) 
suggest that people with diabetes require additional 
protection, other than merely repositioning the 
patient on a specialised mattress, to prevent and 
manage heel pressure ulceration.
CONCLUSION
Pressure ulcers on the heels occur frequently and 
lead to significant morbidity and mortality. All 
patients with diabetes are at risk of developing 
foot problems. Currently, pressure ulcer risk- 
assessment tools do not accurately identify the risk 
factors relating to changes in arterial blood flow, 
neuropathy, and lower limb weakness (Black, 2012). 
In addition, there are inconsistencies about who 
is responsible for the care of patients with diabetes 
that develop heel pressure ulceration while in 
hospital care. The introduction of diabetic foot risk 
assessments on admission into acute care settings, 
together with the recommendation that all patients 
with diabetes who develop heel pressure damage 
should be referred to the MDFCT, could help to 
significantly reduce the risk of lower-extremity 
amputations as a result of heel ulcers. W
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“Management 
of heel ulcers 
requires a thorough 
knowledge of the 
major risk factors 
for ulceration in 
the heel area.”
